November 12, 2007
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Judah Folkman, MD, discussed his role in development of anti-angiogenic drugs
Judah Folkman, MD, discussed his involvement in the development of anti-angiogenic ocular therapy during his keynote address at the opening session of the American Academy of Ophthalmology annual meeting.
|
When Dr. Folkman and colleagues published the first paper on angiogenesis in 1971, "no one believed that tumors needed new blood supply," he said.
Today, multiple angiogenesis inhibitors are used globally to cure a number of ocular diseases, including age-related macular degeneration.